STARTSEITE
Impressum
Datenschutz
  
 
  REVIEW

On the benefit of standard vaccines: tetanus

 
  NEW ON THE MARKET

Idarucizumab (PRAXBIND): antidote for dabigatran

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Red yeast rice: withdrawal of products from the market is overdue

Is it allowed to substitute immediate-release preparations for prolonged-release preparations?

 
  IN BRIEF
 

Rivaroxaban (XARELTO) rehabilitated?

Betahistine (e.g. VASOMOTAL) for MENIÈRE´s disease

Fusafungine (LOCABIOSOL): withdrawal from the market recommended

Misleading trade names of painkillers

Error analysis: BIA 10-2474 in phase 1 testing

 
  CURRENT ADR NETWORK REPORT
 

Urinary incontinence due to safinamide (XADAGO)?

 
  SIDE EFFECTS
 

Dimethyl fumarate (TECFIDERA): first progressive multifocal leukoencephalopathy with only moderate lymphopenia

 

© arznei-telegramm 2/2016